Target intelligence / Profile preview

Bystander single-stranded RNA (Bystander ssRNA)

Target
Bystander ssRNA
Molecular classification
Nucleic acid, Other
01

Overview

Bystander single-stranded RNA (ssRNA) refers to the non-specific RNA molecules that are degraded by certain CRISPR-Cas enzymes, particularly the Cas13 family, upon the successful recognition of a specific target RNA sequence (Abudayyeh et al., 2016, Science). This phenomenon, known as collateral or trans-cleavage, occurs because the binding of the Cas13-gRNA complex to its intended target triggers a conformational change that activates the enzyme's HEPN catalytic domains, which then indiscriminately cleave any nearby ssRNA (Gootenberg et al., 2017, Science). In diagnostic applications such as SHERLOCK, this activity is exploited to cleave synthetic reporter RNA molecules, thereby amplifying the detection signal for pathogens like viruses (Kellner et al., 2019, Nature Protocols). However, in a therapeutic context, the degradation of bystander ssRNA poses a significant safety risk, as it can lead to the unintended destruction of the host cell's transcriptome and subsequent cellular toxicity or death (East-Seletsky et al., 2016, Nature). While this bystander effect can be harnessed to kill specific cells, such as those infected by a virus or harboring oncogenic mutations, its lack of specificity remains a primary hurdle for broad clinical adoption. Consequently, bystander ssRNA is characterized more as a substrate of a specific enzymatic reaction or a source of collateral damage rather than a traditional therapeutic target.

Other names
Collateral RNATrans-cleavage RNANon-specific single-stranded RNAReporter RNA
02

Mechanism of action

Non-specific ribonuclease activity (trans-cleavage) triggered by sequence-specific target recognition

03

Biological functions

RNA degradationSignal amplificationCollateral cleavageOther
04

Disease associations

InfectionCancer
05

Safety considerations

Non-specific transcriptomic degradationCellular toxicityOff-target cell deathSystemic inflammation
06

Interacting drugs

Cas13a (LwaCas13a)

3 more in the full profile.

07

Biomarkers

RNA Integrity Number (RIN)Fluorescent reporter cleavage signal

Beyond the preview

Go deeper on Bystander single-stranded RNA (Bystander ssRNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bystander single-stranded RNA (Bystander ssRNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call